去势
- castrate;emasculate;gonadectomy;ending force
-
(1) [castrate]∶阉割
-
(2) [emasculate]∶使丧失男性生殖力
-
(3) [ending force]∶动作或事情终了时的气势
-
来头大,去势小
-
白蚁干粉混悬剂对去势小鼠性功能及免疫功能的影响
Termite Have Influence on Castrate Mice Especially Sex Function and Immunological Competence
-
去势雌性大鼠骨生物力学性能在运动负荷下的变化
Changes of Biomechanical Function of Bone during Exercise in Castrate Female Rats
-
定量CT对去势兔骨密度观察
Dynamic observation with QCT on bone mineral density of castrated rabbits
-
去势+下颌骨骨缺损组(OVX+mandibularbonedefect,简称O组,27只);
Group O : OVX ( ovariectomy ) + mandibular bone defect , 27 );
-
1α(OH)-D3对去势大鼠下颌骨骨量变化的影响
The effects of 1 α( OH ) - D_3 on bone mass of mandibles in ovariectomized rats
-
六味地黄丸对去势高脂雌鼠雌激素受体α、βmRNA表达的影响
Effect of Liuwei Dihuang Pill on estrogen receptor α,β mRNA expression on emasculatory hyperlipoidemia Rat
-
雄激素对去势大鼠弓状核AR蛋白表达的影响
Effects of Testosterone on Androgen Receptors of Arcuate Nucleus in Rat
-
放疗联合去势术治疗C期病人2年和5年生存率为100%和77%。药物治疗组2年生存率为90%。
In the group of combined treatment , 2 year survival rate is 100 % , and 5 year was 77 % .
-
去势雄性SD大鼠胰岛素敏感性的改变
The change of insulin sensitivity in castrated male SD rats
-
应用免疫组织化学染色的方法检测不同鼠龄的去势大鼠股骨干骺端中RANK的表达。
The expression of RANK in ovariectomized rats femoral Metaphysis was examined with IHC .
-
结果去势后♀大鼠海马和脑皮质组织中APPC端片段的表达升高。
RESULTS APP C terminal fragment expression in both female rat hippocampus and cortex increased significantly after ovariectomy .
-
药物去势治疗前列腺癌D期前列腺癌药物去势的疗效与AR、PSA的相关性研究
Medical castration in the treatment of stage D prostate cancer
-
雄性大鼠去势后下丘脑NOS神经元的分布
Distribution of NOS neurons of hypothalamus in the male rat following castration
-
雌激素对去势大鼠牙槽骨改建过程中IL-6表达的影响
Effect of estrogen on expression of IL-6 in remodeling of osteoporotic alveolar bone in unsex rats
-
乳腺癌术后病人HIFU、RT去势治疗的临床研究&高聚焦超声治疗技术的新应用
The clinical studying of HIFU and RT castrating for breast cancerous patients
-
乳腺癌术后患者HIFU及RT去势治疗的临床研究
The Clinical Study of HIFU and RT Castrating for Breast Cancer Patients
-
雌激素治疗去势雌性大鼠骨质疏松症血清NO、NOS的变化
Changes of serum NO and NOS in OVX rats model of osteoporosis after estrogen therapy
-
前列腺癌荷瘤小鼠药物去势后survivin基因表达的研究
Expression of survivin gene in mice bearing prostate cancer before and after medical castration
-
方法:采用SD大鼠去势后皮下注射丙酸睾酮法复制大鼠前列腺增生模型。称重法观察BWYJ抗BPH的疗效,H。
Methods : grade castrated , SD rat were injected subcutaneously testosterone propionate to induce BPH .
-
雌性大鼠动情周期及去势前后杏仁核内NOS阳性神经元的变化
The Variation of NOS Positive Neurons in Amygdala During the Estrus Cycle and Following Ovariectomy in Female Rat
-
丙酸睾酮对去势beagle犬前列腺上皮细胞的影响
Effect of testosterone propionate on prostatic epithelial cell in castration beagle canine
-
去势后血清性激素变化:模型组较假手术组:血清E2含量明显下降(p<0.01);
The change of serum sex hormone after being emasculated . The content of serum E2 in model group was lower than that of sham operated group ( p0.01 ) .
-
结果:1.补肾增骨方能显著提高去势大鼠骨密度(BMD)水平。
The Method significantly increases Bone mineral density ( BMD ) level of ovariectomized rat . 2 .
-
雌、孕激素对去势雌大鼠血小板聚集、NO和NOS活性的影响
Effects of Estrogen and Progesterone on Platelet Aggregation , Nitric Oxide and Nitric Oxide Synthases activity in ovariectomized rats
-
去势Beagle犬前列腺增生模型的建立
Establishment of Prostatic Hyperplasia Model with Castration Beagle Canines
-
去势组家兔E2水平明显降低,与对照组比较,差异有显著性(P0.05)。
The serum E2 level decreased significantly in the castration group compared with the control group ( P0.05 ) . 3 .
-
对去势组和维甲酸组分别做软骨下骨BMD值和软骨厚度的线性相关图,观察两者之间的关系。
Creating linear correlation to sub-cartilage BMD and articular cartilage thickness of castration group and retinoic acid group .
-
补肾法对去势兔动脉粥样硬化原代培养平滑肌细胞凋亡及血小板源生长因子amRNA等表达的影响
Effects of Kidney-Tonifying Method on Apoptosis and Expressions of PDGF-A mRNA and MCP-1 mRNA in Aorta Primary Cultured Smooth Muscular Cells of Atherosclerosis in the Ovariectomized Rabbit
-
雷洛昔芬对去势大鼠骨组织ER-αmRNA表达水平的研究及其防治绝经后骨质疏松的临床观察
Effects of Raloxifene on Expression of Er - α mRNA in OVX Rat Bone and the Clinical Observation of Its Preventive and Curative Effects on Postmenopausal Woman
-
目的:调查药物去势治疗(AndrogenDeprivationTherapy,ADT)对前列腺癌患者生活质量的影响。
Objective : To investigate the effects of medicine androgen deprivation therapy ( ADT ) on patients with prostate cancer .